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Studies  have  suggested  that  subclinical  hypothyroidism  (SCH)  may  have  detrimental  effects  on  left  ven-
tricular  (LV)  diastolic  function.  Whether  SCH  is a risk  factor  for LV  diastolic  dysfunction  is controversial.
Databases  (MEDLINE,  PubMed,  EMBASE)  were  searched  for  cross-sectional  studies  evaluating  LV diastolic
function in SCH  patients  aged  <60  years  using  tissue  Doppler  echocardiography  (TDE)  and  conventional
two-dimensional  Doppler  echocardiography  (2D-DECG)  published  in  the  past  12 years.  The  weighted
mean  difference  (WMD)  and  95%  conﬁdence  interval  (CI)  were  calculated  using  ﬁxed  or random-effects
models.  We  summarized  the  results  of 14  cross-sectional  studies  with  675  participants.  SCH patients
had  a  signiﬁcantly  lower  LV  mitral  annular  Ea peak  velocity  (WMD  = −1.71  cm/s;  95%CI:  −3.02  to  −0.40;
p  <  0.05),  Ea/Aa ratio  (WMD  =  −0.22;  95%CI:  −0.40  to  −0.05;  p  <  0.05),  and  signiﬁcantly  higher  mitral  annu-
lar  Aa peak  velocity  (WMD  =  0.47  cm/s;  95%CI:  0.10–0.85;  p < 0.05)  than  euthyroid  subjects  using  TDE.
Subgroup  analyses  showed  that  statistical  signiﬁcance  existed  only  in  Ea and  Ea/Aa parameters  when  data
from “women  ≥  90%”  were  used,  and  in the  Aa parameter  when  data  from  “women  < 90%”  were  used.  No
matter  which  subgroup  of  females  was  used,  there  were  signiﬁcant  differences  in LV  peak  transmitral
A  velocity  (WMD  = 7.64 cm/s;  95%CI:  4.55–10.73;  p  < 0.05),  and  E/A  ratio  (WMD  =  −0.22;  95%CI:  −0.31
to  −0.21;  p  < 0.05)  but  no signiﬁcant  difference  in  peak  transmitral  E velocity  (p  > 0.05)  between  SCH
patients  and  euthyroid  controls  using  2D-DECG.  Therefore,  for those  aged  <60  years,  SCH patients  had
signiﬁcantly  worse  parameters  of  LV  diastolic  function  than  euthyroid  controls.
©  2012  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.
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1. IntroductionSubclinical hypothyroidism (SCH) is a common endocrine dis-
order characterized by increased levels of thyroid stimulating
hormone (TSH) with normal levels of free thyroxine (T4) and free
triiodothyronine (T3) in serum. The signs and symptoms of SCH are
vier Ltd. All rights reserved.
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sually subtle as compared with those of overt hypothyroidism, so
t is difﬁcult to detect. Hence the diagnosis of SCH is a laboratory
iagnosis [1].  The controversy about whether screening and treat-
ng SCH is warranted [2] because evidence concerning the risks is
imited; randomized controlled trials on relevant outcomes have
ot been done [3].  SCH has been associated with an increased risk
or atherosclerosis [4],  and meta-analyses have shown that it is also
ssociated with an increased risk of coronary heart disease [5] and
ncreased blood pressure [6].  Several cross-sectional studies have
uggested an association between SCH and left ventricular (LV) dia-
tolic function. However, whether SCH is a risk factor for LV diastolic
unction is controversial.
Tissue Doppler echocardiography (TDE) is a new and powerful
ethod used for the evaluation of regional and global diastolic ven-
ricular function. TDE is used in this way because, compared with
onventional Doppler echocardiography, it is minimally affected
y alterations in afterload, valvular regurgitations, and changes in
eart rate [7,8]. In addition, abnormalities in LV diastolic relaxation
an be observed with respect to physiological parameters in those
ged >60 years.
Hence, to summarize the evidence regarding the relationship
etween SCH and LV diastolic function for those aged <60 years,
e carried out a systematic review and meta-analysis of all cross-
ectional studies published from 1999 to 2011.
. Materials and methods
Our meta-analysis conforms to the Meta-analysis of Observa-
ional Studies in Epidemiology guidelines [9].
.1. Search strategy and selection criteria
MEDLINE, PubMed, and EMBASE electronic databases were
earched for studies published between 1999 and 2011. Stud-
es were identiﬁed using the following Medical Subject Headings
erms “subclinical hypothyroidism,’ “subclinical thyroid dysfunc-
ion,” “thyroid stimulating hormone” and “cardiac function,” “left
entricular functions,” “diastolic dysfunction,” without restrictions
f language and publication form. The reference lists of the obtained
rticles were screened to identify other eligible references, which
ere then retrieved.
Two reviewers independently screened the titles and abstracts
f the search results, and evaluated the remaining full-text articles
or eligibility on the basis of the following criteria: disagreements
ere resolved by consensus. (1) The design was a quantitative
mean and standard deviation (S.D.)], cross-sectional study. (2)
hey reported data on TDE-derived parameters [LV peak early dia-
tolic velocity at the mitral annulus (Ea), peak late diastolic velocity
t the mitral annulus (Aa), and Ea/Aa ratio] [7],  or conventional two-
imensional Doppler echocardiography (2D-DECG) parameters [LV
eak early transmitral ﬂow velocity (E), peak late transmitral ﬂow
elocity (A), and E/A ratio]. (3) In case of parameters’ value from
oth septal and lateral localizations of the mitral annulus, we  con-
idered only the value from septal localization. In addition, TSH
evels are important in diagnosing subclinical diseases. However,
he TSH reference range is still controversial. Several reviews sug-
est a TSH upper limit cutoff of 4.5–5.0 mU l−1, but others suggest
ecreasing the upper limit of the TSH range to 2.5–3.0 mU l−1
10,11]. In the absence of consensus, we did not pre-specify a TSH
utoff value to deﬁne SCH.
.2. Exclusion criteriaStudies were excluded if the mean age of subjects was  >60
ears, because abnormalities in LV diastolic relaxation could be
bserved in physiological parameters in those older than 60 years;iology 61 (2013) 8–15 9
if they examined cardiac function not using TDE or 2D-DECG; or
if the study population had been derived from patients with a
history of cardiovascular disease, arterial systemic hypertension,
diabetes mellitus, respiratory, hematological, liver, or kidney dis-
eases, because all of these diseases raise the likelihood of SCH [3].  All
participants who  had clinical diseases or were taking thyroid med-
ications were excluded. We  also excluded the literature in which
information was  incomplete or unavailable.
2.3. Statistical analysis
Meta-analysis was conducted using STATA version 11.0 (Stata
Corp., College Station, TX, USA) utilizing the METAN and METBIAS
modules [12]. The indicators of LV diastolic function in each study
were extracted as mean ± S.D. When not reported, we contacted the
authors of the study. If the units of parameters were not uniform,
we transformed them into the same unit. The pooled effects were
presented as weighted mean differences (WMD)  with 95% conﬁ-
dence intervals (CI) using ﬁxed or random effects models [13,14].
Heterogeneity of the studies was  assessed using the Cochran Q
statistic [15] and quantiﬁed by I2, which represents the percentage
of total variation across studies that is attributable to heterogene-
ity rather than chance [16]. Subgroup analyses were carried out to
investigate between-study heterogeneity focusing on female pro-
portion (women %) of the study. We  classiﬁed female proportion as
“women ≥ 90%,” and “women < 90%.” This is because SCH prevails
in women  with antithyroid antibodies [17] and cardiac functional
abnormalities are associated with SCH in older women [18]. Sen-
sitivity analysis was  carried out to evaluate whether results were
inﬂuenced by a single study. Finally, to assess the extent of publi-
cation bias, the Begg’s adjusted rank correlation test [19] and the
Egger’s regression asymmetry test [20] for publication bias were
used.
3. Results
3.1. Selected studies and characteristics
Of the 1354 reports identiﬁed, we excluded 1333 studies that
were unrelated to the association between SCH and LV function.
Twenty-one articles were reviewed to determine the eligibility
for the systematic review. With respect to inclusion criteria, we
excluded 2 studies that did not contain speciﬁc data on SCH (deﬁned
as an elevated TSH level) and 2 studies that did not have out-
come data. We  also eliminated 2 studies because they did not use
echocardiography to examine LV function. In addition, 1 study was
excluded because the mean age of subjects was >60 years.
Thus, for our systematic review, we summarized the results of
14 cross-sectional studies with 675 participants [18,21–33].  Table 1
shows the characteristics of all 14 studies included in our analysis.
Tables 2 and 3 provide data on the indicators of LV diastolic function
for patients with SCH and euthyroid controls using TDE and/or 2D-
DECG.
3.2. TDE
The overall pooled results of the Ea parameter with random
effects analyses showed that the Ea parameter was decreased sig-
niﬁcantly in patients with SCH (WMD  = −1.71 cm/s; 95%CI: −3.02 to
−0.40; p = 0.011). In the subgroup of “women ≥ 90%,” there was  a
signiﬁcant decrease in the Ea parameter (WMD  = −3.02 cm/s;
95%CI: −4.39 to −1.64; p = 0.000). There was, however,
no signiﬁcant decrease in the subgroup of “women < 90%”
(WMD  = −0.83 cm/s; 95%CI: −2.71 to 1.06; p = 0.390) (Fig. 1A).
Heterogeneity was  inﬂuenced mainly by two extreme results
from the studies by Arinc et al. [25] and Akcakoyun et al. [23].
10 X. Chen et al. / Journal of Cardiology 61 (2013) 8–15
Fig. 1. Forrest plots of WMDs  of Ea, Aa, and Ea/Aa parameters associated with SCH in the “women ≥ 90%” and “women < 90%” studies. Ea, peak early diastolic velocity at the
mitral  valve annulus; Aa, peak late diastolic velocity at the mitral valve annulus; CI, conﬁdence interval; WMD, weighted mean difference; EUT, euthyroidism; SCH, subclinical
hypothyroidism.
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Table  1
Characteristics of the studies included in the meta-analysis.
Study Years of
publication
Country Cases number
(SCH/EUT)
Mean age
(or range)
Sex of cases
(women %)
TSH cutoff
(mU  l−1)
Equipment used in
examining cardiac function
Erkan et al. [21] 2011 Turkey 42(22/20) 18–60 100% 4.2–10 2D-DECG; TDE
Oner  et al. [22] 2011 Turkey 49(27/22) 35 90% >4.20 2D-DECG; TDE
Akcakoyun et al. [23] 2009 Turkey 48(23/25) 35 58% >4.0 2D-DECG; TDE
Mariotti et al. [24] 2007 Italy 31(18/13) 40.7 94% >3 2D-DECG; TDE
Arinc et al. [25] 2006 Turkey 44(22/22) 47.5 68% >4.0 2D-DECG; TDE
Fabrizio et al. [26] 2006 Italy 48(24/24) 34.4 79% 3.5–7.5 2D-DECG; TDE
Franzoni et al. [27] 2006 Italy 72(42/30) 51.5 69% >3.6 2D-DECG; TDE
Zoncu et al. [28] 2005 Italy 35(22/13) 41.2 94% >3 2D-DECG; TDE
Kosar et al. [29] 2005 Turkey 64(36/28) 37.6 89% >4.4 2D-DECG; TDE
Yazici et al. [30] 2004 Turkey 74(45/29) 39 85% >4.0 2D-DECG;
Vitale et al. [18] 2002 Italy 40(20/20) 38.3 100% >3.0 2D-DECG; TDE
Monzani et al. [31] 2001 Italy 40(20/20) 33 90% >3.6 2D-DECG;
Bello  et al. [32] 2000 Italy 32(16/16) 33.1 88% >3.6 2D-DECG;
Biondi et al. [33] 1999 Italy 56(26/30) 36 86% >3.0 2D-DECG;
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sex might be a confounding factor in the relationship between LVbbreviations: 2D-DECG = conventional two-dimensional Doppler echocardiog
UT  = euthyroidism.
f our study was omitted from the analysis (Q = 7.03 on 4 df;
 = 0.135; I2 = 43.1%), a signiﬁcant WMD  of −2.66 cm/s remained
95%CI: −3.43 to –1.89; p = 0.000). Likewise, there was no evidence
f signiﬁcant heterogeneity across 6 studies that reported the
a parameter (Q = 1.99 on 5 df; p = 0.851; I2 = 0.00%). Hence, the
MD  of the pooled Aa parameter with the ﬁxed effect model
howed that the Aa parameter was substantially higher in the SCH
roup compared with the control group (WMD  = 0.47 cm/s; 95%CI:
.10–0.85; p = 0.012). This signiﬁcance remained when data from
he “women < 90%” (WMD  = 0.52 cm/s; 95%CI: 0.08–0.95; p = 0.019)
as included. There was, however, no signiﬁcant difference in the
ubgroup of “women ≥ 90%” (WMD  = 0.36 cm/s; 95%CI: −0.36 to
.07; p = 0.331) (Fig. 1B). The Ea/Aa ratio was the most common
ariable of diastolic function. We  observed a borderline signiﬁ-
antly decreased Ea/Aa parameter in the SCH group (WMD  = −0.24;
5%CI: −0.48 to −0.00; p = 0.048) when data from “women ≥ 90%”
ere pooled. However, a signiﬁcant association was  not found
hen studies were restricted to those from “women < 90%”
WMD  = −0.20; 95%CI: −0.48 to 0.08; p = 0.167). The pooled WMD
ased on all results was  −0.22 (95%CI: −0.40 to −0.05; p = 0.013)
Fig. 1C). The test for heterogeneity was no longer signiﬁcant after
emoving the most extreme result from the study by Arinc et al.
25] (Q = 6.97 on 4 df; p = 0.138; I2 = 42.6%), and the pooled WMD  of
he Ea/Aa ratio did not change considerably (WMD  = −0.31; 95%CI:
0.43 to −0.19; p = 0.000). Fig. 1 shows the WMD  of Ea, Aa, and
a/Aa parameters associated with SCH, respectively.
.3. 2D-DECG
Data from “women ≥ 90%” and “women < 90%” studies showed
 signiﬁcantly increased peak late transmitral ﬂow velocity (A)
ssociated with SCH. The pooled WMD  based on these stud-
es was 7.64 cm/s (95%CI: 4.55–10.73; p = 0.000) (Fig. 2A). There
as, however, evidence of signiﬁcant heterogeneity between the
tudies (Q = 40.01 on 12 df; p = 0.000; I2 = 70.0%). The test for het-
rogeneity was no longer signiﬁcant after removing the three
xtreme results from the studies by Franzoni et al. [27], Vitale
t al. [18], and Monzani et al. [31] (Q = 11.51 on 9 df; p = 0.242;
2 = 21.8%), and the estimated WMD  did not change considerably
WMD  = 8.21 cm/s; 95%CI: 5.74–10.68; p = 0.000). In addition, the
ooled WMD  of the E/A ratio (a sensitive parameter of diastolic
ysfunction) was also signiﬁcantly lower in the patients group
WMD  = −0.22; 95%CI: −0.31 to −0.21; p = 0.000). When data from
tudies of “women ≥ 90%” were combined, there was  a signiﬁ-
ant decrease in the E/A ratio in the patients group (WMD  = −0.16;
5%CI: −0.28 to −0.04; p = 0.009). The “women < 90%” studies also; TDE = tissue Doppler echocardiography; SCH = subclinical hypothyroidism;
suggested a positive association (WMD  = −0.27; 95%CI: −0.38 to
−0.15; p = 0.000) (Fig. 2B). Heterogeneity among the 12 results
from these studies was  substantially higher (Q = 60.08 on 11 df;
p = 0.000; I2 = 81.7%). The heterogeneity was  inﬂuenced mainly by
three slightly signiﬁcant results from the studies by Erkan et al.
[21], Yazici et al. [30], and Vitale et al. [18]. If our study was omitted
from the analysis (Q = 13.93 on 8 df; p = 0.084; I2 = 42.6%), a signif-
icant WMD  of −0.28 remained (95%CI: −0.36 to −0.21; p = 0.000).
Nevertheless, by combining the data across all 13 studies, we did
not observe a signiﬁcant relationship between peak early transmi-
tral ﬂow velocity (E) and SCH (WMD  = −3.40 cm/s; 95%CI: −8.43 to
1.63; p = 0.185) (Fig. 2C). Fig. 2 shows the WMD  of E, A, and the
parameters of the E/A ratio associated with SCH.
3.4. Publication bias
The Begg’s adjusted rank correlation test and Egger’s regres-
sion asymmetry test did not demonstrate substantial evidence of
publication bias in most parameters. However, the A parameter
presented a slight publication bias among the contributing stud-
ies (p = 0.020 and 0.004, respectively). Table 4 is a summary of the
results of Begg’s and Egger’s tests.
4. Discussion
In our systematic review, we identiﬁed studies and undertook a
meta-analysis of 14 cross-sectional studies to determine the associ-
ation between SCH and LV diastolic function. Similar to the included
studies, we evaluated LV diastolic function using: peak transmi-
tral E and A velocity; the E/A ratio; peak mitral annular Ea and Aa
velocity; and Ea/Aa parameters. We  found that, in SCH patients,
no matter which subgroup of females was  used, peak transmitral
A velocity was  signiﬁcantly higher and the E/A ratio signiﬁcantly
lower as compared with controls, but that there was  no signiﬁ-
cant difference in mitral E velocity. That is, conventional 2D-DECG
could be used to reveal diastolic dysfunction in SCH patients by
the increased A parameter, which resulted in a reduction in the E/A
ratio. Nevertheless, the pooled results of TDE-derived parameters
showed a signiﬁcant relationship between SCH and all parameters
of diastolic function (peak mitral annular Ea, Aa velocity, and their
ratio (Ea/Aa)). Due to the higher prevalence of SCH in women [34],diastolic function and SCH. Thus, we created subgroups by female-
dominated (90%) objects (which was  the mid-point of the included
literature sorted by the percentage of women) and subgroup anal-
yses showed that statistical signiﬁcance was observed only in the
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Table 2
Data on the parameters of LV diastolic function using TDE and conventional 2D-DECG in the included studies.
Parameters Erkan et al. [21] Oner et al. [22] Akcakoyun et al. [23] Mariotti et al. [24] Arinc et al. [25] Fabrizio et al. [26] Franzoni et al. [27]
SCH (n = 22) EUT (n = 20) SCH (n = 27) EUT (n = 22) SCH (n = 23) EUT (n = 25) SCH (n = 18) EUT (n = 13) SCH (n = 22) EUT (n = 22) SCH (n = 24) EUT (n = 24) SCH (n = 42) EUT (n = 30)
E (cm/s) 84 ± 14 86 ± 13 90 ± 10 90 ± 10 83 ± 18 79 ± 14 61 ± 13 70 ± 10 74 ± 19 77 ± 18 71.2 ± 15.7 81.2 ± 13.0 39.4 ± 6.1 56.6 ± 6.3
Ea (cm/s) 11.45 ± 3.24 13.24 ± 2.44 13 ± 3 16 ± 3 11.2 ± 1.6 11.6 ± 2.1 NA NA 11.6 ± 2.9 9.8 ± 2.4 9.8 ± 2.7 11.4 ± 2.0 NA NA
A  (cm/s) 64 ± 16 60 ± 11 80 ± 20 70 ± 10 64 ± 8 59 ± 9 59 ± 10 53 ± 11 77 ± 18 66 ± 12 67.5 ± 10.7 52.4 ± 9.6 51.9 ± 7.5 49.8 ± 8.1
Aa (cm/s) 9.15 ± 2.28 8.65 ± 1.39 10 ± 3 10 ± 2 NA NA NA NA 10.2 ± 2.9 9.7 ± 2.1 8.9 ± 2.4 7.7 ± 1.7 NA NA
E/A  1.39 ± 0.33 1.44 ± 0.15 1.2 ± 0.3 1.4 ± 0.2 NA NA 1.0 ± 0.2 1.4 ± 0.3 1.1 ± 0.5 1.2 ± 0.3 1.1 ± 0.2 1.5 ± 0.3 0.76 ± 0.2 1.16 ± 0.3
Ea/Aa 1.52 ± 0.58 1.63 ± 0.25 1.39 ± 0.61 1.52 ± 0.31 NA NA NA NA 1.2 ± 0.4 1.0 ± 0.5 1.1 ± 0.2 1.5 ± 0.3 NA NA
Abbreviations: E = peak early diastolic transmitral ﬂow velocity; Ea = peak early diastolic velocity at mitral annulus; A = peak late diastolic transmitral ﬂow velocity; Aa = peak late diastolic velocity at mitral annulus; NA = not
available;  SCH = subclinical hypothyroidism; EUT = euthyroidism; All results are expressed as mean ± S.D.
Table 3
Data on the parameters of LV diastolic function using TDE and conventional 2D-DECG in the included studies.
Parameters Zoncu et al. [28] Kosar et al. [29] Yazici et al. [30] Vitale et al. [18] Monzani et al. [31] Bello et al. [32] Biondi et al. [33]
SCH (n = 22) EUT (n = 13) SCH (n = 36) EUT (n = 28) SCH (n = 45) EUT (n = 29) SCH (n = 20) EUT (n = 20) SCH (n = 20) EUT (n = 20) SCH (n = 16) EUT (n = 16) SCH (n = 26) EUT (n = 30)
E (cm/s) 61.05 ± 11.23 69.93 ± 9.92 NA NA 95.7 ± 13.4 99.2 ± 15.3 69 ± 5 68 ± 4 91 ± 17 82 ± 15 89 ± 18 84 ± 13 74 ± 13 79 ± 11
Ea (cm/s) 10.99 ± 2.35 15.21 ± 2.5 9.5 ± 1.1 12.3 ± 1.3 NA NA NA NA NA NA NA NA NA NA
A  (cm/s) 57.02 ± 9.45 52.79 ± 10.58 NA NA 83.4 ± 12.6 74.3 ± 13.5 51 ± 5 50 ± 5 77 ± 16 56 ± 13 71 ± 14 58 ± 14 55 ± 13 48 ± 9
Aa (cm/s) 10.84 ± 1.94 10.38 ± 1.72 10.2 ±  1.2 9.8 ± 0.8 NA NA NA NA NA NA NA NA NA NA
E/A 1.09  ± 0.26 1.36 ± 0.27 NA NA 1.19 ± 0.18 1.34 ± 0.17 1.35 ± 0.08 1.37 ± 0.11 1.3 ± 0.3 1.4 ± 0.4 1.3 ± 0.3 1.5 ± 0.4 1.4 ± 0.3 1.7 ± 0.3
Ea/Aa 1.04 ± 0.28 1.53 ± 0.47 0.93 ± 0.24 1.25 ± 0.33 NA NA NA NA NA NA NA NA NA NA
Abbreviations: E = peak early diastolic transmitral ﬂow velocity; Ea = peak early diastolic velocity at mitral annulus; A = peak late diastolic transmitral ﬂow velocity; Aa = peak late diastolic velocity at mitral annulus; NA = not
available;  SCH = subclinical hypothyroidism; EUT = euthyroidism; All results are expressed as mean ± S.D.
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Fig. 2. Forrest plots of WMDs  of A, E/A, and E parameters associated with SCH in the “women ≥ 90%” and “women < 90%” studies. E, peak early transmitral ﬂow velocity; A,
peak  late transmitral ﬂow velocity; CI, conﬁdence interval; WMD, weighted mean difference; EUT, euthyroidism; SCH, subclinical hypothyroidism.
14 X. Chen et al. / Journal of Card
Table 4
The summary results of the Begg’s and Egger’s test for publication bias.
Tissue Doppler echocardiography 
Ea Aa Ea/A
Begg’s test P = 0.881 P = 0.851 P = 0.1
Egger’s  test P = 0.485 P = 0.692 P = 0.2
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[bbreviations:  E = peak early diastolic transmitral ﬂow velocity; Ea = peak early diast
ate  diastolic velocity at mitral annulus.
P < 0.05.
a and Ea/Aa parameter when data from “women ≥ 90%” were used,
nd in the Aa parameter when data from “women < 90%” were used.
urther studies are needed with both sexes to conﬁrm whether
he association is affected by sex. In addition, we  considered only
ubjects aged <60 years because abnormalities in LV diastolic relax-
tion could be observed in physiological parameters in those older
han 60 years.
Interpretation of our results requires caution due to several
ources of bias. First, misclassiﬁcation of SCH could explain cardiac
ysfunction. The SCH deﬁnition used in each study was  not identi-
al. There were different upper limits of the TSH level, which may
ave included a lower TSH level, which could affect cardiac dysfunc-
ion. In addition, the etiology of SCH was mainly Hashimoto disease
n the selected studies; chronic autoimmune thyroiditis, thyroidec-
omy were not mentioned. Because of the non-feasibility of creating
ubgroups according to the cause of SCH, whether Hashimoto dis-
ase affected cardiac dysfunction could not be determined. Second,
he proﬁle of transmitral ﬂow velocity is affected by several factors,
ncluding volume status, left atrial pressure, age, sex, and heart rate
35]. It could appear pseudo-normal, which would generate dia-
tolic dysfunction that would not be displayed when LV pressure
as raised further in an earlier diastolic period [36]. Fortunately,
issue Doppler imaging is a powerful new method to evaluate
V diastolic function. Also, TDE-derived parameters are sensitive
ndices that can be used to discriminate between pseudo-normal
nd normal values because TDE is a relatively preload-independent
ariable that can be used to evaluate diastolic function. In addi-
ion, mitral annulus velocity at the lateral annulus shows a higher
alue compared with that obtained at the septal side. Therefore,
he location of sample volume should be considered in the diag-
osis of diastolic function by mitral annulus velocity [37]. Finally,
ublication bias is an important problem in medicine. It occurs
ecause studies are published (to some extent) based on the sig-
iﬁcance of the ﬁndings. In our analyses, evidence of publication
ias was not found with standard tests in TDE-derived parameters.
owever, there was a slight publication bias in the A parameter of
D-DECG. The presence or absence of heterogeneity did not appear
o affect signiﬁcantly the results of our analysis because similar
esults were observed when the studies (sources of heterogeneity)
ere excluded from the analysis.
Bias or uncontrolled confounding could have accounted for LV
iastolic dysfunction among subjects with SCH but some plausi-
le biological mechanisms are worthy of consideration. The heart
s one of the major target organs of thyroid hormones. Thyroid
ysfunction has an important role in the cardiovascular system
ecause it affects the sarcoplasmic reticulum, contractile proteins,
nd the membranes of myocardial cells [38]. Biological changes
n the myocardium can induce LV diastolic dysfunction [39]. In
ddition, a deﬁciency in thyroid hormones alters the function of
ardiac muscle by decreasing the activity of enzymes involved in
he regulation of calcium intake and expression of several contrac-
ile proteins in cardiomyocytes. Thyroid-hormone deﬁciency leads
o a decrease in heart rate and impairment of myocardial contrac-
ion and relaxation [40]. Conversely, earlier deﬁciency of thyroid
ormones could lead to TSH release, whereas T3 and T4 remain in
[
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Conventional two-dimensional Doppler echocardiography
a E A E/A
88 P = 0.625 P = 0.020a P = 1.000
36 P = 0.301 P = 0.004a P = 0.060
elocity at mitral annulus; A = peak late diastolic transmitral ﬂow velocity; Aa = peak
the normal range. It is also assumed that elevated levels of TSH in
patients with SCH do not reﬂect pituitary compensation to main-
tain euthyroidism but probably represent SCH. Therefore, based on
the understanding of these cellular and physiological mechanisms
of action of thyroid hormones on the heart and cardiovascular sys-
tem, the changes in cardiac diastolic function, cardiac contractility,
blood pressure, and vascular resistance that result from thyroid
dysfunction can be explained [41]. In addition, Biondi et al. [17]
showed that SCH prevails in elderly women  with antithyroid anti-
bodies. Also, the results of a prospective study of SCH patients have
shown that the annual risk of developing overt hypothyroidism is
greater in women and approximately twofold higher in those with
antithyroid antibodies. However, the mechanism responsible for
this phenomenon remains has not been clariﬁed.
5. Conclusion
Our meta-analysis suggested that SCH patients had signiﬁcantly
worse parameters of LV diastolic function than euthyroid subjects
aged <60 years. Accordingly, the association between abnormal
LV diastolic functional parameters and SCH suggests that further
clinical trials are needed to explore whether thyroxine therapy is
a potential preventative strategy for patients with SCH to avoid
cardiac dysfunction [42,43].
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